How lipid mediators promote the resolution of inflammatory skin disease

MRC · United Kingdom government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The skin is a crucial barrier between the environment and the internal body, and as such it is home to a plethora of immune cells ready to respond to invading pathogens. However, these cells must remain tolerant to harmless environmental substances and commensal microbes. Therefore, the activity of skin immune cells must be tightly regulated to prevent inappropriate activation and subsequent inflammation. In recent years it has become clear that this regulation is not passive, but is actively maintained by regulatory mechanisms including cell surface receptors, cell-cell interactions and the secretion of regulatory molecules. Dysregulation of these regulatory mechanisms leads to chronic inflammation, such as that seen in the chronic inflammatory skin diseases, psoriasis and atopic dermatitis (eczema). Whilst the involvement of proteins in this active regulation of inflammation has been studied, the involvement of lipid mediators remains a relatively unexplored area of research. This is despite the skin being a highly lipid rich tissue. This project will profile the bioactive lipid mediators present in skin throughout the induction, peak and resolution of inflammatory responses, to identify signalling lipids involved in regulating inflammation. The mechanisms by which these lipids regulate inflammation will be determined using in vitro and in vivo immune cell activity assays, and the potential to manipulate these lipids to suppress inflammation will be examined. This project will provide training in key techniques such as pre-clinical models of inflammatory disease (psoriasis and atopic dermatitis), flow cytometry, cell culture and immunological assays, ELISA, QPCR and lipidomic analysis by mass spectrometry. This project will identify novel regulation of immune cell activity by bioactive lipids. These findings will pave the way for novel therapeutic strategies for the treatment of psoriasis and atopic dermatitis, which are highly prevalent inflammatory skin...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2022
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Global Travel, Accommodation and Venue Management Services
Capital Programme Delivery Framework(s)
NEPRO Total Talent
Technology Products and Associated Services 3
Workforce Solution 2
Technology Products and Associated Services 3
GMCA 2201 NW Regional Children’s Services Contract
Integrated Partnerships Framework

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.